GPR52 MODULATORS AND METHODS OF USE

The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical com...

Full description

Saved in:
Bibliographic Details
Main Authors Ashweek, Neil J, Cueva-Garcia, Juan Pablo, Regan, Collin
Format Patent
LanguageEnglish
Published 27.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present disclosure are directed to methods useful in the treatment or prophylaxis of a neurological disease or disorder and conditions related thereto.
Bibliography:Application Number: US202117919483